Who we are: Founded in 1906, the ASBMB has a storied history of advancing the mechanistic understanding of nature through promotion of the highest-quality research in biochemistry and molecular biology.
What we do: The society is committed to advancing scientific knowledge by publishing and reporting on significant and enduring research.
Why us?: ASBMB journals are committed to helping scientists disseminate their findings in the most efficient and effective way. We strive to keep review times short, provide useful feedback and promote contributions after publication. As always, our publications are free to any reader, increasing visibility and ensuring research equity.
Journal of Biological Chemistry
The Journal of Biological Chemistry focuses on science at the intersection of chemistry and biology, illuminating the mechanistic details of biological processes.
All accepted manuscripts are available to the public for free on the day of acceptance. The average time from submission to first decision is 17 days for regular articles and shorter for accelerated communications.
Explore JBC papers:
- Editors’ Picks — the top-rated papers published in JBC accompanied by commentaries and author profiles.
- JBC Reviews — authoritative analysis of topics including recent advances in specialized areas, methodologies and technology, and interdisciplinary research.
- Classics — highlighting breakthrough papers published in JBC with context about the field and authors.
- Reflections — scientific memoirs by trailblazers in the field of biological chemistry.
Explore JLR papers:
- Thematic Reviews — a series of articles on a hot lipid-related topic appearing in consecutive issues.
- Patient-Oriented and Epidemiological Research articles — based on human data collected for genetic or characterization studies.
- Commentaries — highlighting an especially significant article, JLR editorial board members discuss the importance of the research and examine its potential consequences.
- Images in Lipid Research — peer-reviewed, one-page articles celebrating scientists and the images they create.
In 2000, the human genome was announced as completed. But it was filled with gaps, and did not represent humanity’s genetic diversity. Read and watch a short film about recent updates.
A destructive disease can lurk in a citrus plant’s vascular system. Misfolded proteins offer a key to inflammation in liver disease. And proteomic studies provide clues about signaling linked to neurological disorders.
For small-molecule cancer drugs, context is everything. Drugs that ameliorate cancer in some tissues may increase the cancer risk in others. Researcher Stephen Safe has turned this challenge into an opportunity.